Article Text

Download PDFPDF
Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
  1. S Bar-Meir,
  2. Z Halpern,
  3. M Gutman,
  4. Z Shpirer,
  5. M Baratz,
  6. D Bass


    Forty patients with biopsy proven chronic active hepatitis were studied, 22 received (+)-cyanidanol-3 in a dose of 3 g daily and 18 placebo. Side effects related to cyanidanol were fever (four patients), haemolysis (one patient) and urticaria (one patient). All side effects subsided on discontinuation of the medication. Cyanidanol had an effect no better than placebo on symptoms, laboratory tests, and histological findings on liver biopsy.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.